1536.00 - 1565.00
1090.00 - 1784.00
46.2K / 155.6K (Avg.)
23.48 | 66.41
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-24.62%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-33.51%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-111.85%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-117.20%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-137.24%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-136.70%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-136.70%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
No Data
No Data available this quarter, please select a different quarter.
-0.00%
Reduced diluted shares while 6247.T is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-90.22%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-8.51%
Negative 5Y CAGR while 6247.T stands at 24.17%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-27.32%
Negative 3Y CAGR while 6247.T stands at 4.87%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
100.00%
Positive long-term OCF/share growth while 6247.T is negative. John Neff would see a structural advantage in sustained cash generation.
100.00%
Positive OCF/share growth while 6247.T is negative. John Neff might see a comparative advantage in operational cash viability.
No Data
No Data available this quarter, please select a different quarter.
99.07%
Positive 10Y CAGR while 6247.T is negative. John Neff might see a substantial advantage in bottom-line trajectory.
-153.08%
Negative 5Y net income/share CAGR while 6247.T is 141.12%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-130.63%
Negative 3Y CAGR while 6247.T is 772.57%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
216.88%
5Y equity/share CAGR above 1.5x 6247.T's 28.74%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
185.73%
3Y equity/share CAGR above 1.5x 6247.T's 24.34%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
2.64%
AR growth of 2.64% while 6247.T is zero. Bruce Berkowitz wonders if the firm’s additional AR is warranted by strong revenue or potential risk.
1.51%
Inventory shrinking or stable vs. 6247.T's 26.28%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
0.48%
Asset growth well under 50% of 6247.T's 4.17%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
0.26%
Under 50% of 6247.T's 1.20%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
23.08%
Debt growth of 23.08% while 6247.T is zero. Bruce Berkowitz sees additional leverage that must yield profitable expansions to be worthwhile.
No Data
No Data available this quarter, please select a different quarter.
-3.10%
We cut SG&A while 6247.T invests at 0.11%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.